Intravenous immunoglobulin contains high-titer neutralizing IgG antibodies to SARS-CoV-2

Am J Transplant. 2022 Oct;22(10):2484-2485. doi: 10.1111/ajt.17086. Epub 2022 May 12.

Authors

Stanley C Jordan¹, Anders Berg², Bongha Shin¹, Ashley Vo¹, Noriko Ammerman¹, Ruan Zhang¹

Affiliations

¹ Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, California, USA.
² Department of Pathology & Lab Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Neutralizing
Antibodies, Viral
COVID-19*
Humans
Immunoglobulin M
Immunoglobulins, Intravenous / therapeutic use
SARS-CoV-2*

Substances

Antibodies, Neutralizing
Antibodies, Viral
Immunoglobulin M
Immunoglobulins, Intravenous